Episodes

  • 2025 State of the Air: Dangers of the Air We Breathe with George Thurston, ScD

    2025 State of the Air: Dangers of the Air We Breathe with George Thurston, ScD
    May 13 2025
    An internationally recognized leader in air quality, epidemiology and exposure assessment, George Thurston, ScD, of New York University headlines this important episode analyzing the Lung Association’s 2025 “State of the Air” report. With nearly half of the people living in the U.S. breathing unhealthy amounts of air pollution, Thurston delves into the acute and accumulative health impacts on communities across the country. Listen in to learn more about the report’s key learnings, from adverse effects of exposure to ground-level ozone pollution to the decade-long worsening trend of particle pollution.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
    32 mins
  • Lung Cancer Screening: A Decade of Lessons Learned with Mary Pasquinelli, DNP

    Lung Cancer Screening: A Decade of Lessons Learned with Mary Pasquinelli, DNP
    Apr 22 2025
    It has been more than a decade since lung cancer screening guidelines via low-dose CT, based on the USPSTF’s B recommendations, have been put into place. To discuss the guidelines’ ambitions and obstacles, we are joined by the University of Illinois Health System’s Mary Pasquinelli, DNP, who specializes in lung cancer, lung cancer screening and pulmonary nodule management. While a lifesaving procedure for at-risk individuals, the uptake of screening on a population-level—though increasing—has been slower than expected.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
    36 mins
  • After the Smoke: Wildfire Cleanup & Air Quality Concerns with Afif El-Hasan, MD

    After the Smoke: Wildfire Cleanup & Air Quality Concerns with Afif El-Hasan, MD
    Feb 24 2025
    For this hot topic, asthma and lung health expert Dr. Afif El-Hasan of Kaiser Permanente in California joins host Dr. Albert Rizzo to discuss the acute effects of wildfire smoke on air quality. The enlightening conversation also covers the massive cleanup efforts from the recent Los Angeles wildfires and how related exposures may pose health risks.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
    15 mins
  • Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD

    Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
    Jan 27 2025
    In this episode, Dr. Meredith McCormack of Johns Hopkins University and Dr. Loretta Que of Duke University to discuss “race-based normal values” in medicine, particularly in regard to pulmonary function tests (PFT).

    The controversial practice of using a patient’s self-reported race to adjust a standard “normal” range has been shown to lead to potential misdiagnosis and healthcare disparities. Drs. McCormack and Que talk at length about their key roles in the growing movement to phase out a reliance on race in PFT interpretation.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
    21 mins
  • This Year in Pulmonology: The 2024 Lungcast Recap

    This Year in Pulmonology: The 2024 Lungcast Recap
    Jan 10 2025
    Ever since the show first launched, Lungcast has provided pulmonologists and health care providers in general a chance to take part in ongoing conversations regarding lung health between experts, patients, and patient advocates.

    In this recap episode, the Lungcast team reflects on these conversations by highlighting some of the many interviews featured in 2024. The following are a set of examples of this year’s interviews, though several other memorable episodes are not on this list. We hope you enjoy this set of highlights.

    For more, view a summary here: https://www.hcplive.com/view/this-year-in-pulmonology-a-2024-lungcast-recap

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
    19 mins
  • 2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob Sands

    2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob Sands
    Dec 7 2024
    For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targeted mutations, Dr. Sands addresses how precision oncology is fundamentally changing lung cancer diagnosis and treatment.

    The novel immunotherapy drugs, though proven to be safe and effective with significant improvements in response and survival rates, have challenges as well—this episode covers the gamut.

    Episode Highlights

    0:00 Start

    1:00 Topic of discussion

    2:42 Introducing Jacob Sands, MD

    3:39 NCCN guidelines for lung cancer

    6:51 Recently-approved drugs for lung cancer

    13:46 Patient responses to targeted mutations

    17:58 Off-target side effects with drugs

    21:34 State of Lung Cancer report

    23:04 Estimated number of candidates for targeted therapies

    26:13 Insurance coverage for biomarker testing

    28:12 Other issues with ordering biomarkers

    31:20 Closing comments

    32:36 Outro

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
    33 mins
  • Physician, Patient & Partner Perspectives on AERD with Dr. Mitchell Grayson, Rhonda Nelson & Wayne Nelson

    Physician, Patient & Partner Perspectives on AERD with Dr. Mitchell Grayson, Rhonda Nelson & Wayne Nelson
    Nov 13 2024
    In this episode, multiple points of view are presented regarding Asthma Exacerbated Respiratory Disease (AERD). Lungcast host Albert Rizzo, MD, was joined by allergist and immunologist Mitchell Grayson, MD, of Nationwide Children’s Hospital, as well as patient advocate Rhonda Nelson and her husband Wayne Nelson of The Little River Band. This discussion delves into the trials and tribulations of diagnosing—and living with—AERD, from disease misconceptions to daily management.

    Join the discussion as these guests focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.

    Episode Highlights
    0:00 Start
    1:00 Focus of each guest
    2:55 Sampter’s triad and AERD
    6:30 Patient experiences with AERD
    10:18 Delayed diagnosis and recent changes
    11:35 Therapy for AERD
    16:32 Resources for patients with asthma
    19:01 Day-to-day AERD management
    24:14 Importance of keeping a medical journal
    27:42 Outro

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
    29 mins
  • The Quest to Intercept Lung Disease with Drs. Ravi Kalhan, Amy Olson & George Washko

    The Quest to Intercept Lung Disease with Drs. Ravi Kalhan, Amy Olson & George Washko
    Oct 29 2024
    Episode Highlights
    0:15     Intro
    1:10 Introducing the Lung Health Cohort Research Study
    3:49 The enrollment strategy
    7:10 Seeking “the cholesterol of lung disease”
    11:50 The role of industry support
    14:09 Imaging strategies for long-term lung assessment
    17:59 Recruitment challenges
    23:05 Final thoughts
    26:20 Outro

    For our 50th episode, Ravi Kalhan, MD, of Northwestern Medicine, George Washko, MD, of Harvard University, and Amy Olson, MD, Executive Director of Medical Affairs for Boehringer Ingelheim Pharmaceuticals, Inc, join us for a panel discussion around improving patient outcomes through innovative lung health research, such as with the American Lung Association Lung Health Cohort Research Study.

    Tune in to learn more about their collaborative efforts to help identify biomarkers and lifestyle patterns for more accurate identification of disease processes, ideally at onset.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
    27 mins